Clinical Trials Directory

Trials / No Longer Available

No Longer AvailableNCT03896815

Expanded Access Use of INCB054329 to Treat a Single Patient With Metastatic Renal Cell Carcinoma

Status
No Longer Available
Phase
—
Study type
Expanded Access
Enrollment
—
Sponsor
Incyte Corporation · Industry
Sex
—
Age
—
Healthy volunteers
—

Summary

Expanded access use of INCB054329 to treat a single patient with metastatic renal cell carcinoma.

Interventions

TypeNameDescription
DRUGINCB054329

Timeline

First posted
2019-04-01
Last updated
2019-04-01

Source: ClinicalTrials.gov record NCT03896815. Inclusion in this directory is not an endorsement.

Expanded Access Use of INCB054329 to Treat a Single Patient With Metastatic Renal Cell Carcinoma (NCT03896815) · Clinical Trials Directory